PFIZER
|
PFIZER Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 167.78 | 120.51 | 136.38 | 133.89 | 108.77 |
| CEPS(Rs) | 181.07 | 134.12 | 159.44 | 159.03 | 132.68 |
| DPS(Rs) | 165.00 | 35.00 | 70.00 | 30.00 | 35.00 |
| Book NAV/Share(Rs) | 921.84 | 785.91 | 701.05 | 626.10 | 523.07 |
| Tax Rate(%) | 24.46 | 26.10 | 24.28 | 20.74 | 25.59 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 31.01 | 27.43 | 31.60 | 30.79 | 31.82 |
| EBIT Margin(%) | 42.91 | 32.88 | 32.71 | 28.86 | 30.56 |
| Pre Tax Margin(%) | 42.56 | 32.21 | 32.18 | 28.46 | 29.87 |
| PAT Margin (%) | 32.15 | 23.81 | 24.37 | 22.56 | 22.23 |
| Cash Profit Margin (%) | 34.70 | 26.49 | 28.49 | 26.79 | 27.12 |
| Performance Ratios | |||||
| ROA(%) | 17.03 | 13.65 | 16.09 | 17.24 | 13.00 |
| ROE(%) | 19.65 | 16.21 | 20.55 | 23.30 | 17.19 |
| ROCE(%) | 26.21 | 22.37 | 27.56 | 29.78 | 23.62 |
| Asset Turnover(x) | 0.53 | 0.57 | 0.66 | 0.76 | 0.58 |
| Sales/Fixed Asset(x) | 1.72 | 1.71 | 1.90 | 2.07 | 1.75 |
| Working Capital/Sales(x) | 0.81 | 1.06 | 1.39 | 1.80 | 2.04 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.58 | 0.58 | 0.53 | 0.48 | 0.57 |
| Receivable days | 29.10 | 26.74 | 20.98 | 16.89 | 22.89 |
| Inventory Days | 69.53 | 67.09 | 61.77 | 59.41 | 70.57 |
| Payable days | 76.77 | 95.85 | 109.35 | 114.15 | 176.59 |
| Valuation Parameters | |||||
| PER(x) | 23.86 | 34.80 | 25.40 | 32.50 | 41.57 |
| PCE(x) | 22.11 | 31.27 | 21.73 | 27.36 | 34.08 |
| Price/Book(x) | 4.34 | 5.34 | 4.94 | 6.95 | 8.64 |
| Yield(%) | 4.12 | 0.83 | 2.02 | 0.69 | 0.77 |
| EV/Net Sales(x) | 6.80 | 7.82 | 5.77 | 7.00 | 8.74 |
| EV/Core EBITDA(x) | 17.01 | 21.01 | 15.37 | 20.33 | 24.67 |
| EV/EBIT(x) | 15.15 | 22.51 | 16.71 | 23.31 | 28.61 |
| EV/CE(x) | 3.68 | 4.76 | 4.36 | 4.74 | 6.02 |
| M Cap / Sales | 8.03 | 8.75 | 6.54 | 7.62 | 9.24 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 4.02 | -9.55 | -7.13 | 16.64 | 4.04 |
| Core EBITDA Growth(%) | 11.86 | -10.35 | 1.27 | 13.24 | 4.86 |
| EBIT Growth(%) | 34.55 | -9.07 | 6.88 | 14.54 | 4.68 |
| PAT Growth(%) | 39.23 | -11.64 | 1.86 | 23.10 | -2.26 |
| EPS Growth(%) | 39.23 | -11.64 | 1.86 | 23.10 | -2.26 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 6.17 | 5.01 | 3.79 | 2.77 | 2.42 |
| Quick Ratio(x) | 5.33 | 4.22 | 3.16 | 2.24 | 1.87 |
| Interest Cover(x) | 120.54 | 49.35 | 62.13 | 73.23 | 44.45 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹23,362.3 Cr | -2.8% | -2.1% | 1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -2.8% |
-2.1% |
1.6% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses
